Endovia Health Sciences EDVA
NYSE EDVA
$0.26 +0.00 (+0.00%)
As of: Sep 3, 2026 · 11:52 AM EDT

Endovia Health Sciences (EDVA) Total Liabilities (2011 - 2026)

Analysis

Endovia Health Sciences (EDVA) Total Liabilities (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 141.50 Bn 133.65 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 86.53 Bn 78.54 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 65.05 Bn 59.86 Bn 1.37 Bn 1.62 Bn
4 Moderna 57.11 Bn 51.98 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.71 Bn 44.71 Bn - 1.72 Bn
6 BeOne Medicines 40.40 Bn 35.31 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.36 Bn 32.05 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.16 Bn 27.32 Bn - 10.03 Bn
9 Insmed 27.40 Bn 26.24 Bn 358.27 Mn 1.35 Bn
10 Endovia Health Sciences 801,166.21 558,464.21 - 16.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.83 Mn
Mar 31, 2026 16.97 Mn
Dec 31, 2025 16.27 Mn
Sep 30, 2025 15.71 Mn
Jun 30, 2025 13.52 Mn
Mar 31, 2025 22.54 Mn
Dec 31, 2024 21.39 Mn
Sep 30, 2024 19.19 Mn
Jun 30, 2024 18.41 Mn
Mar 31, 2024 18.06 Mn
Dec 31, 2023 15.50 Mn
Sep 30, 2023 11.90 Mn
Jun 30, 2023 9.16 Mn
Mar 31, 2023 7.76 Mn
Dec 31, 2022 7.98 Mn
Sep 30, 2022 5.97 Mn
Jun 30, 2022 5.41 Mn
Mar 31, 2022 6.10 Mn
Dec 31, 2021 7.51 Mn
Sep 30, 2021 9.52 Mn